BENATTI, Piero
 Distribuzione geografica
Continente #
NA - Nord America 16.785
AS - Asia 6.955
EU - Europa 5.924
SA - Sud America 929
AF - Africa 144
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 30.769
Nazione #
US - Stati Uniti d'America 16.580
SG - Singapore 2.651
GB - Regno Unito 2.471
CN - Cina 1.637
HK - Hong Kong 752
BR - Brasile 715
IT - Italia 672
VN - Vietnam 596
SE - Svezia 589
DE - Germania 572
UA - Ucraina 361
FI - Finlandia 321
BD - Bangladesh 272
TR - Turchia 264
FR - Francia 251
RU - Federazione Russa 251
KR - Corea 171
IN - India 138
BG - Bulgaria 121
CA - Canada 101
AR - Argentina 69
IQ - Iraq 65
ID - Indonesia 64
MX - Messico 58
JP - Giappone 51
NL - Olanda 49
BE - Belgio 46
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 41
IE - Irlanda 41
ES - Italia 40
PK - Pakistan 39
EC - Ecuador 29
CL - Cile 27
CO - Colombia 27
UZ - Uzbekistan 27
MY - Malesia 26
VE - Venezuela 26
AU - Australia 23
DZ - Algeria 20
PL - Polonia 20
MA - Marocco 19
CZ - Repubblica Ceca 16
LT - Lituania 16
NP - Nepal 16
PH - Filippine 16
SA - Arabia Saudita 16
TH - Thailandia 16
TW - Taiwan 16
AT - Austria 14
EG - Egitto 12
JO - Giordania 11
KE - Kenya 11
PY - Paraguay 11
IL - Israele 10
AZ - Azerbaigian 9
PE - Perù 9
TN - Tunisia 9
PT - Portogallo 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
JM - Giamaica 7
DK - Danimarca 6
HU - Ungheria 6
IR - Iran 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
CH - Svizzera 5
CR - Costa Rica 5
KZ - Kazakistan 5
PA - Panama 5
PR - Porto Rico 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
GR - Grecia 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SN - Senegal 4
AM - Armenia 3
BH - Bahrain 3
CG - Congo 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
LK - Sri Lanka 3
OM - Oman 3
PS - Palestinian Territory 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
BZ - Belize 2
EE - Estonia 2
EU - Europa 2
Totale 30.728
Città #
Southend 1.847
Singapore 1.836
Santa Clara 1.386
Ashburn 1.308
Fairfield 1.192
Woodbridge 866
Chicago 828
Hong Kong 743
Houston 716
Chandler 663
Jacksonville 627
San Jose 593
Los Angeles 534
Wilmington 502
Dearborn 500
Ann Arbor 477
Seattle 452
Hefei 432
Cambridge 431
Salt Lake City 364
Nyköping 352
Beijing 317
London 274
Helsinki 196
New York 186
Council Bluffs 183
Elk Grove Village 179
Ho Chi Minh City 174
Izmir 161
Tampa 160
Hanoi 153
The Dalles 146
Seoul 137
Princeton 128
Modena 125
San Diego 120
Sofia 119
Dallas 115
Eugene 113
Lancaster 95
Sterling 94
Frankfurt am Main 93
Lauterbourg 92
Buffalo 82
Milan 80
Shanghai 79
Bremen 70
Miami 66
Des Moines 64
Moscow 64
Munich 56
São Paulo 56
Columbus 50
Detroit 46
Dulles 43
Falls Church 42
Phoenix 41
Tokyo 39
Dublin 38
Orem 38
Brussels 35
Da Nang 35
Atlanta 34
Kansas City 33
Fremont 32
Jakarta 31
Pittsburgh 31
Haiphong 29
Rome 29
Rio de Janeiro 27
Toronto 26
Chennai 25
Guangzhou 25
Hounslow 25
Mexico City 25
Tashkent 25
Nanjing 24
Ottawa 24
Kunming 23
Baghdad 22
Belo Horizonte 20
Jersey City 20
Norwalk 19
Dhaka 18
San Francisco 18
Changsha 17
Denver 17
Turku 17
Boardman 16
Curitiba 16
Montreal 16
Amsterdam 15
Manchester 15
Mumbai 15
Hải Dương 14
Philadelphia 14
Brasília 13
Brooklyn 13
Chiswick 13
Miano 13
Totale 21.842
Nome #
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 489
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 459
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 454
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 443
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 438
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 435
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 430
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 420
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 411
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 409
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 401
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 393
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 390
Microsatellite instability in multiple colorectal tumors 386
Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics 384
Aetiology of colorectal cancer and relevance of monogenic inheritance. 381
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 378
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 375
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 375
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 370
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 361
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 361
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 355
Survival from salivary glands adenoid cystic carcinoma in European populations. 354
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 352
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 344
The non-invasive mechanical ventilation: the experience of the department of Internal Medicine and Critical Area of the Polyclinic Hospital of Modena 342
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 337
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 334
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 332
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 329
Myeloperoxidase-positive cell infiltration of normal colorectal mucosa is related to body fatness and is predictive of adenoma occurrence 325
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 324
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 322
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 321
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 320
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 320
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 317
Clinical features of colorectal cancer patients in advanced age: a population-based approach 314
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 305
Microsatellite instability and colorectal cancer prognosis. 303
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 302
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 300
Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States 297
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 296
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 296
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 292
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 289
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 288
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 287
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 285
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 277
Colorectal carcinoma in different age groups: A population based investigation 274
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 270
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 269
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 269
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 268
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 266
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 265
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients] 260
Biological characterization of mucinous carcinoma of the colon and rectum 259
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 258
Clinical and biologic heterogeneity of Hereditary NonPolyposis Colorectal Cancer. 256
Survival from rare cancer in adults: A population-based study 254
Collection of Italian hereditary non-polyposis colorectal cancer (HNPCC) pedigrees 251
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. 246
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 243
Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome 242
Clinical features and genotype-phenotype correlations in 41 Italian families with Adenomatosis Coli 242
Prevalence of differentiated thyroid cancer is relevant in patients with familial adenomatous polyposis: a case-control, prospective study 238
Survival for colon and rectal cancer in a population-based cancer registry 234
Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy 231
Italian cancer figures, report 2013: Multiple tumours 231
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. 229
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 228
Phenotype-genotype correlations in an extended family with adenomatosis coli and an unusual APC gene mutation 225
Frequency and type of colorectal tumors in asymptomatic high-risk individuals in families with hereditary nonpolyposis colorectal cancer 219
Il registro dei tumori colorettali 215
Microsatellite instability and prognosis of colorectal cancer 212
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 209
CANCER OCCURRENCE IN THE FOLLOW-UP OF 25 FAMILIES WITH HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER (HNPCC) 204
The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis 204
HMSH6 immunohistochemistry in patients with clinical suspicion of Hereditary Non-Polyposis Colorectal Cancer. 203
Inheritance and susceptibility to tumours of the large bowel: A new classification of colorectal malignancies 199
Epidemiology of cancer of the large bowel - The 12-year experience of a specialized registry in Northern Italy 199
Caratterizzazione immunoistochimica e biomolecolare del carcinoma colorettale giovanile 199
Genetic epidemiology of Hereditary Non-Polyposis Colorectal Cancer syndromes in Modena, Italy: results of a complex segregation analysis. 196
Higher prevalence of nodular goiter and thyroid carcinoma in patients with familial adenomatous poliposis (FAP) 194
Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis 191
Epidemiologia dei tumori del colon-retto. Incidenza, mortalità, familiarità e sopravvivenza nella ex USL di Modena, 1984-1998. 187
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer 187
GENETIC EPIDEMIOLOGY OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER 186
MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. 182
Higher prevalence of nodular goiter and thyroid carcinoma in patients with familial adenomatous poliposis (FAP) 180
Identification and biomolecular characterization of Muir-Torre Syndrome 178
Two different marker panels for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 174
A West Nile Virus infection expressed as unilateral limb paralysis and complicated by Parsonage–Turner syndrome: a case report 173
Two different marker panels for microsatellie instability analysis in detection of constitutional MLH1 and MSH2 mutations. 171
Genotype-phenotype association in Italian HNPCC families:preliminary results and proposal of a National collaborative study. 170
Totale 29.103
Categoria #
all - tutte 126.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.100 44 340 166 142 39 88 143 76 221 138 470 233
2022/20231.821 224 194 145 172 229 314 20 165 204 12 83 59
2023/20241.288 48 69 77 80 351 130 123 157 30 23 64 136
2024/20254.685 145 60 68 337 1.011 710 340 285 465 176 462 626
2025/202611.752 554 336 670 1.806 3.712 552 1.064 452 801 777 525 503
2026/20275 5 0 0 0 0 0 0 0 0 0 0 0
Totale 30.877